These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9818657)

  • 21. Perceived influence of health status on sexual activity in RA patients: associations with demographic and disease-related variables.
    Helland Y; Dagfinrud H; Kvien TK
    Scand J Rheumatol; 2008; 37(3):194-9. PubMed ID: 18465454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression in psoriatic arthritis: role of time varying clinical indicators.
    Gladman DD; Farewell VT
    J Rheumatol; 1999 Nov; 26(11):2409-13. PubMed ID: 10555902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is a condition-specific instrument for patients with low back pain/leg symptoms really necessary? The responsiveness of the Oswestry Disability Index, MODEMS, and the SF-36.
    Walsh TL; Hanscom B; Lurie JD; Weinstein JN
    Spine (Phila Pa 1976); 2003 Mar; 28(6):607-15. PubMed ID: 12642770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description and prediction of physical functional disability in psoriatic arthritis: a longitudinal analysis using a Markov model approach.
    Husted JA; Tom BD; Farewell VT; Schentag CT; Gladman DD
    Arthritis Rheum; 2005 Jun; 53(3):404-9. PubMed ID: 15934101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsiveness of fibromyalgia clinical trial outcome measures.
    Dunkl PR; Taylor AG; McConnell GG; Alfano AP; Conaway MR
    J Rheumatol; 2000 Nov; 27(11):2683-91. PubMed ID: 11093454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis.
    Katchamart W; Benjamanukul S; Chiowchanwesawakit P
    Int J Rheum Dis; 2014 Feb; 17(2):181-5. PubMed ID: 24618364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after Colles fracture: the relative responsiveness of three questionnaires and physical examination measures.
    Amadio PC; Silverstein MD; Ilstrup DM; Schleck CD; Jensen LM
    J Hand Surg Am; 1996 Sep; 21(5):781-7. PubMed ID: 8891974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health.
    Kievit W; Welsing PM; Adang EM; Eijsbouts AM; Krabbe PF; van Riel PL
    Arthritis Rheum; 2006 Oct; 55(5):745-50. PubMed ID: 17013821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis.
    Kosinski M; Zhao SZ; Dedhiya S; Osterhaus JT; Ware JE
    Arthritis Rheum; 2000 Jul; 43(7):1478-87. PubMed ID: 10902749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T; Pope JE
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
    Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM
    Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.
    Teng YK; Verburg RJ; Sont JK; van den Hout WB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2005 Aug; 52(8):2272-6. PubMed ID: 16052541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
    Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
    Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.